Literature DB >> 33630327

Rethinking Human Embryo Research Policies.

Kirstin R W Matthews, Ana S Iltis, Nuria Gallego Marquez, Daniel S Wagner, Jason Scott Robert, Inmaculada de Melo-Martín, Marieke Bigg, Sarah Franklin, Soren Holm, Ingrid Metzler, Matteo A Molè, Jochen Taupitz, Giuseppe Testa, Jeremy Sugarman.   

Abstract

It now seems technically feasible to culture human embryos beyond the "fourteen-day limit," which has the potential to increase scientific understanding of human development and perhaps improve infertility treatments. The fourteen-day limit was adopted as a compromise but subsequently has been considered an ethical line. Does it remain relevant in light of technological advances permitting embryo maturation beyond it? Should it be changed and, if so, how and why? What justifications would be necessary to expand the limit, particularly given that doing so would violate some people's moral commitments regarding human embryos? Robust stakeholder engagement preceded adoption of the fourteen-day limit and should arguably be part of efforts to reassess it. Such engagement could also consider the need for enhanced oversight of human embryo research. In the meantime, developing and implementing reliable oversight systems should help foster high-quality research and public confidence in it.
© 2021 The Hastings Center.

Entities:  

Keywords:  embryo; fourteen-day limit; guidelines; policy; research ethics

Year:  2021        PMID: 33630327     DOI: 10.1002/hast.1215

Source DB:  PubMed          Journal:  Hastings Cent Rep        ISSN: 0093-0334            Impact factor:   2.683


  2 in total

Review 1.  Pathology of hyperandrogenemia in the oocyte of polycystic ovary syndrome.

Authors:  Neil R Chappell; William E Gibbons; Chellakkan S Blesson
Journal:  Steroids       Date:  2022-02-18       Impact factor: 2.668

Review 2.  ISSCR Guidelines for Stem Cell Research and Clinical Translation: The 2021 update.

Authors:  Robin Lovell-Badge; Eric Anthony; Roger A Barker; Tania Bubela; Ali H Brivanlou; Melissa Carpenter; R Alta Charo; Amander Clark; Ellen Clayton; Yali Cong; George Q Daley; Jianping Fu; Misao Fujita; Andy Greenfield; Steve A Goldman; Lori Hill; Insoo Hyun; Rosario Isasi; Jeffrey Kahn; Kazuto Kato; Jin-Soo Kim; Jonathan Kimmelman; Jürgen A Knoblich; Debra Mathews; Nuria Montserrat; Jack Mosher; Megan Munsie; Hiromitsu Nakauchi; Luigi Naldini; Gail Naughton; Kathy Niakan; Ubaka Ogbogu; Roger Pedersen; Nicolas Rivron; Heather Rooke; Janet Rossant; Jeff Round; Mitinori Saitou; Douglas Sipp; Julie Steffann; Jeremy Sugarman; Azim Surani; Jun Takahashi; Fuchou Tang; Leigh Turner; Patricia J Zettler; Xiaomei Zhai
Journal:  Stem Cell Reports       Date:  2021-05-27       Impact factor: 7.765

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.